These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8329041)

  • 1. DLIS affects digoxin interpretation.
    Lee KR; Phelps SJ
    Am Pharm; 1993 Mar; NS33(3):6. PubMed ID: 8329041
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Chinese medicine "kyushin" on serum digoxin concentration measurement in dogs.
    Lin CS; Lin MC; Chen KS; Liu CB
    Jpn Circ J; 1989 Feb; 53(2):108-12. PubMed ID: 2716172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
    Dasgupta A; Nakamura A; Doria L; Dennen D
    Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B; Durand A; Labadie N; Cano JP
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
    Yannakou L; Diamandis EP; Souvatzoglou A
    Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA; Oldfield PR; Murphy GM; Lawson AM
    Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of blood digoxin].
    Janssen K
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1254. PubMed ID: 2201511
    [No Abstract]   [Full Text] [Related]  

  • 13. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of marked digoxin-like immunoreactivity in the human adrenal cortex: results of an immunohistochemical study.
    Ghione S; Balzan S; Braus S; Montali U; Bruno J
    Eur J Histochem; 1993; 37(3):273-6. PubMed ID: 7693066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-like substance in amniotic fluid--fact or artifact?
    Greenway DC; Nanji AA
    Gynecol Obstet Invest; 1986; 22(2):108-9. PubMed ID: 3770531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.